CARAPELLUCI, Maud ; Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie
Bertrand, Olivier ; Université de Liège - ULiège > Département des sciences cliniques > Médecine interne générale ; Centre de recherche de l'Institut universitaire de cardiologie et de pneumonie de Québec, Québec, Canada
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Language :
English
Title :
Drug-coated balloons for coronary bifurcations lesions: a new approach in the ‘BioPCI’ era?
Fang H, Wang T, Zhang L, et al.Evaluating IVUS-guided PCI in acute myocardial infarction: a comparative meta-analysis with angiography guidance. Acta Cardiol. 2025;80(8):862–870. doi:10.1080/00015385.2025.2529133.
Minten L, Dubois C, Desmet W, et al.Economical aspects of coronary angiography for diagnostic purposes: a Belgian perspective. Acta Cardiol. 2024;79(1):41–45. doi:10.1080/00015385.2023.2281105.
Lunardi M, Louvard Y, Lefèvre T, et al.Definitions and standardized endpoints for treatment of coronary bifurcations. EuroIntervention. 2023;19(10):e807–e831. doi:10.4244/EIJ-E-22-00018.
Fezzi S, Scheller B, Rissanen T, et al.Drug-coated balloons for coronary bifurcation lesions. EuroIntervention. 2025;21(20):e1177-1197–e1197. doi:10.4244/EIJ-D-25-00201.
Jim MH, Lee MK, Fung RC, et al.Six-month angiographic result of supplementary paclitaxel-eluting balloon deployment to treat side branch ostium narrowing (SARPEDON). Int J Cardiol. 2015;187:594–597. doi:10.1016/j.ijcard.2015.04.002.
Kleber FX, Rittger H, Ludwig J, et al.Drug eluting balloons as stand-alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol. 2016;105(7):613–621. doi:10.1007/s00392-015-0957-6.
Jing QM, Zhao X, Han YL, et al.A drug-eluting Balloon for the trEatment of coronarY bifurcatiON lesions in the side branch: a prospective multicenter ranDomized (BEYOND) clinical trial in China. Chin Med J (Engl). 2020;133(8):899–908. doi:10.1097/CM9.0000000000000743.
Gao X, Tian N, Kan J, et al.Drug-coated balloon angioplasty of the side branch during provisional stenting: the multicenter randomized DCB-BIF trial. J Am Coll Cardiol. 2025;85:1–15.
Corballis NH, Paddock S, Gunawardena T, et al.Drug coated balloons for coronary artery bifurcation lesions: a systematic review and focused meta-analysis. PLoS One. 2021;16(7):e0251986. doi:10.1371/journal.pone.0251986.
Jiang ZM, Liu L., Drug-coated versus uncoated balloon for side branch protection in coronary bifurcation lesions treated with provisional stenting using drug-eluting stents: a meta-analysis. Int J Clin Pract. 2022;2022(1):5892589. doi:10.1155/2022/5892589.
Dohi T, Ishihara T, Kida H, et al.Comparison of drug-coated versus conventional balloons for the side branch of the bifurcation lesion–multicenter randomized controlled study–(OCVC-BIF): design and rationale. Cardiovascular Revascularization Medicine. 2025;81:57–61. doi:10.1016/j.carrev.2025.03.024.
Pan L, Lu W, Han Z, et al.Drug-coated balloon in the treatment of coronary left main true bifurcation lesion: a patient-level propensity-matched analysis. Front Cardiovasc Med. 2022;9:1028007. doi:10.3389/fcvm.2022.1028007.
Her A-Y, Kim TH, Shin E-S, et al.Drug-coated balloon-based treatment of left main true bifurcation lesion. Catheter Cardiovasc Interv. 2025;105(5):1024–1031.
Huber MS, Mooney JF, Madison J, et al.Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol. 1991;68(5):467–471. doi:10.1016/0002-9149(91)90780-o.
Lee T, Ashikaga T, Nozato T, et al.Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions. EuroIntervention. 2024;20(13):e818-25–e825. doi:10.4244/EIJ-D-23-01006.
Albertal M, Van Langenhove G, Regar E, et al.Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting. Heart. 2001;86(2):193–198. doi:10.1136/heart.86.2.193.
